LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease

The pentatricopeptide repeat (PPR) family plays a major role in RNA stability, regulation, processing, splicing, translation, and editing. Leucine-rich PPR-motif-containing protein (LRPPRC), a member of the PPR family, is a known gene mutation that causes Leigh syndrome French-Canadian. Recently, gr...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in physiology Vol. 10; p. 595
Main Authors: Cui, Jie, Wang, Li, Ren, Xiaoyue, Zhang, Yamin, Zhang, Hongyi
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 24-05-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pentatricopeptide repeat (PPR) family plays a major role in RNA stability, regulation, processing, splicing, translation, and editing. Leucine-rich PPR-motif-containing protein (LRPPRC), a member of the PPR family, is a known gene mutation that causes Leigh syndrome French-Canadian. Recently, growing evidence has pointed out that LRPPRC dysregulation is related to various diseases ranging from tumors to viral infections. This review presents available published data on the LRPPRC protein function and its role in tumors and other diseases. As a multi-functional protein, LRPPRC regulates a myriad of biological processes, including energy metabolism and maturation and the export of nuclear mRNA. Overexpression of LRPPRC has been observed in various human tumors and is associated with poor prognosis. Downregulation of LRPPRC inhibits growth and invasion, induces apoptosis, and overcomes drug resistance in tumor cells. In addition, LRPPRC plays a potential role in Parkinson's disease, neurofibromatosis 1, viral infections, and venous thromboembolism. Further investigating these new functions of LRPPRC should provide novel opportunities for a better understanding of its pathological role in diseases from tumors to viral infections and as a potential biomarker and molecular target for disease treatment.
Bibliography:content type line 23
SourceType-Scholarly Journals-1
This article was submitted to Mitochondrial Research, a section of the journal Frontiers in Physiology
Edited by: Vito De Pinto, Università degli Studi di Catania, Italy
Reviewed by: Hua Lou, Case Western Reserve University, United States; Dhanendra Tomar, Temple University, United States
ISSN:1664-042X
1664-042X
DOI:10.3389/fphys.2019.00595